Olema Pharmaceuticals, Inc. (OLMA)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

10

0

2

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Nov-24 6:00 AM View:	15-Nov-24 Option Exercise $175.50K	Kovacs Shane William Charles Ch. Operating & Financial Off.		Olema Pharmaceuticals, Inc. - OLMA	20% 424.99K to 510.46K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 10:00 PM View:	05-Mar-24 Disposition (other) 0	Rappaport Andrew Director		Olema Pharmaceuticals, Inc. - OLMA	(20%) 481.01K to 385.96K	0	0	--	--	Show Txns Hide Txns

06-Jun-24 5:01 PM View:	04-Jun-24 Private Sale ($17.45M)	Graham G. Walmsley Director		Olema Pharmaceuticals, Inc. - OLMA	(67%) 4.25M to 1.41M	0	0	--	--	Show Txns Hide Txns

28-May-24 5:00 PM View:	24-May-24 Option Exercise $46.07K	Zojwalla Naseem CHIEF MEDICAL OFFICER		Olema Pharmaceuticals, Inc. - OLMA	193% 30.66K to 89.82K	0	0	--	--	Show Txns Hide Txns

31-Jul-24 5:15 PM View:	30-Jul-24 Sale (Planned) ($14.52K)	Harmon Cyrus Director		Olema Pharmaceuticals, Inc. - OLMA	(19%) 1.07M to 873.31K	0	0	--	--	Show Txns Hide Txns

08-Dec-23 4:19 PM View:	06-Dec-23 Purchase $1.16M	Paradigm Biocapital Advisor... 10% Owner		Olema Pharmaceuticals, Inc. - OLMA	1% 7.8M to 7.9M	0	0	--	--	Show Txns Hide Txns